Biomatter Series A: $18M

Nov 12, 2026Verified by OSH — Confirmed by at least two independent sources or a primary document (filing, official announcement).

Biomatter raised $18 million in a series a round led by Astanor, announced Nov. 12.

Facts

Company: Biomatter
Amount: $18 million
Currency: USD
Stage: Series A
Announced: Nov 12, 2026
Instrument: Equity

Investors

Led by: Astanor
Participants: UVC Partners Inventure Partners Metaplanet

Use of funds

Establish a 2,000-square-metre enzyme design and testing facility in Vilnius and expand commercial operations in the United States.

As stated by the company.

Sources

1.Lithuania’s Biomatter raises $18M for AI enzyme design and a US push — thenextweb.com
2.MATI and IITA Partner, Biomatter Raises $18 Million | GrowinAgri Daily — growinagri.substack.com
3.Biomatter lands $18M to speed up enzyme development with AI — Tech.eu, Nov 12, 2026
4.Biomatter: $18 Million Series A To Expand AI-Designed Enzyme Platform — Pulse 2.0, Nov 12, 2026

Verified by OSH — Confirmed by at least two independent sources or a primary document (filing, official announcement).Last verified Nov 13, 2026